Essential Partners »

Actuate Therapeutics shares owned by Essential Partners

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $132 48 2.75

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Comfort Sys Usa Stock (FIX)
Nvidia Corporation Stock (NVDA)
Schwab Fundamental Int'l Broad Etf (FNDF)
iShares S&P 500 Etf (IVV)
Schwab Fundamental U.S. Broad Etf (FNDB)
Vanguard Short-Term USTS Etf (VGSH)
General Mtrs Stock (GM)
Ge Aerospace Stock (GE)
Merck & Co Stock (MRK)
Technipfmc Stock (FTI)
Ge Vernova Stock (GEV)
Teradyne Stock (TER)
Incyte Corp Stock (INCY)
Pnc Finl Svcs Group Stock (PNC)

View all positions for Essential Partners

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Northern Trust
Texas Capital Bank Wealth Management Services
Vanguard Fiduciary Trust
State Street Corporation
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group
Deutsche Bank Aktiengesellschaft

View all funds holding Actuate Therapeutics